Author:
Bennett S,Wise R,Weston D,Dent J
Abstract
A combination of 3 g of ticarcillin and 200 mg of clavulanic acid was administered intravenously to six healthy male volunteers, after which the concentrations of these agents in serum and blister fluid were measured. The ratio of the two drugs in serum varied from 15:1 (ticarcillin-clavulanic acid) at the time of administration to 28:1 at 30 min and 62:1 at 5 h after injection. Both agents penetrated blister fluid rapidly, the ratio being 33:1 at 1 h and 66:1 at 3 h. The elimination rates of these agents were different, but for each compound they were similar in serum and blister fluid.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference11 articles.
1. In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin;Hunter P. A.;J. Antimicrob. Chemother.,1980
2. Jackson D. 1982. Augmentin: human pharmacokineticsdiscussion p. 52-54. In D. A. Leigh and 0. P. W. Robinson (ed.) Augmentin clavulanate potentiated amoxycillin. Proceedings of the 2nd symposium. Excerpta Medica Amsterdam.
3. Comparative in vitro activity and clinical pharmacology of ticarcillin and carbenicillin;Neu H. C.;Antimicrob. Agents Chemother.,1975
4. Combined activity of clavulanic acid and ticarcillin against ticarcillinresistant gram-negative bacilli;Paisley J. W.;Antimicrob. Agents Chemother.,1978
5. Clavulanic acid: a ,- lactamase-inhibiting P-lactam from Streptomyces clavuligerus;Reading C.;Antimicrob. Agents Chemother.,1977
Cited by
68 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献